Scutellaria: Debates on the anticancer property - 11/07/18
pages | 12 |
Iconographies | 3 |
Vidéos | 0 |
Autres | 0 |
Highlights |
• | Scutellaria a member of the Labiatae family is an important plant of traditional medicine. |
• | The cytotoxic/anticancer activity of Scutellaria on different types of cancer was described and discussed. |
• | Scutellaria introduced as a potential plant for the treatment of different cancer. |
• | The therapeutic effects of Scutellaria are related to presence of flavonoid and terpene compounds. |
Abstract |
The widespread use of plants as accessible anticancer agents leads to the identification of many natural source chemotherapeutic agents. Scutellaria one of the popular genus of flowering plants has been used for various human illnesses for thousands of years. Scutellaria has anti-metastatic, anti-proliferative, anti-invasion, anti-angiogenic and apoptosis effects in vitro as well as in vivo. Despite numerous reports on the cytotoxic-antitumor activity of the plant, there are still some issues need further consideration. Issues such as unjustified interpretations, lack of attention to the pharmacokinetics profile and weak study design may affect the final decision about the use of plants as anticancer agents and possibly needs reconsideration. In this review, we have summarized the potential health benefits of Scutellaria and its active components also the underlying mechanism of cytotoxicity and antitumor activity. Meanwhile we have discussed concerns may interfere with the precise conclusion.
Le texte complet de cet article est disponible en PDF.Abbreviation : Bcl-2, 5-FU, TGF-β1, PTEN, HIF-1α, MAPK, CRC, SHH, IL6, STAT3, ERK, Nrf2, UCP2, FOXM1, ER, FNFR, MMP-2 and MMP-9, UPA, UPAR, EMT, IGF-1, ERα, mTOR, ADR, SCLC, NSCLC, TCM, Runx3, FOXO3, RHOA, iNOS, HPV, MEK, AMKL, NPM, UVB
Keywords : Scutellaria, Anti-Angiogenic, Apoptosis, Anti-Proliferative, Anti-Invasion
Plan
Vol 105
P. 1299-1310 - septembre 2018 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’achat d’article à l’unité est indisponible à l’heure actuelle.
Déjà abonné à cette revue ?